Chemomab Reports Positive Results in Nebokitug Phase 2 PSC Open Label Extension Trial Showing Continued Broad and Substantial Improvements in Key Liver Biomarkers
Stock Information for Lexicon Pharmaceuticals Inc.
Loading
Please wait while we load your information from QuoteMedia.